Syra Health is a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions. Syra Health aims to achieve its goal by becoming a valuable partner to government, payers, providers, life sciences organizations, and academic institutions. Syra Health offers products and services in digital health, behavioral and mental health, population health management, health education, and healthcare workforce. For more information, please visit www.syrahealth.com.
Company profile
Ticker
SYRA
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
SYRA stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
25 Apr 24
ARS
2023 FY
Annual report to shareholders
24 Apr 24
DEF 14A
Definitive proxy
24 Apr 24
8-K
Departure of Directors or Certain Officers
28 Mar 24
8-K
Results of Operations and Financial Condition
25 Mar 24
10-K
2023 FY
Annual report
25 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Syra Health Announces Third Quarter 2023 Financial Results
14 Nov 23
S-8
Registration of securities for employees
6 Oct 23
8-K
Syra Health Corp. Announces Pricing of Upsized Initial Public Offering
4 Oct 23
Latest ownership filings
SC 13G
McAleer Mike Edward
20 Feb 24
SC 13G/A
SLS GROUP LLC
13 Feb 24
SC 13G/A
SLS GROUP LLC
24 Jan 24
4
Sandeep Allam
26 Dec 23
4
Feroz Syed
26 Dec 23
4
Deepika Vuppalanchi
26 Dec 23
SC 13G
McAleer Mike Edward
11 Oct 23
4
Ketan Paranjape
10 Oct 23
4
Andrew Dahlem
10 Oct 23
4
Sherron Rogers
10 Oct 23
Financial summary
Quarter (USD) | Sep 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 18.01 mm | 18.01 mm | ||||
Cash burn (monthly) | 114.34 k | (no burn) | ||||
Cash used (since last report) | 794.15 k | n/a | ||||
Cash remaining | 17.22 mm | n/a | ||||
Runway (months of cash) | 150.6 | n/a |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Dec 23 | Sandeep Allam | Class A Common Stock | Buy | Acquire P | No | No | 1.31 | 294 | 385.14 | 3,730 |
14 Dec 23 | Feroz Syed | Class A Common Stock | Buy | Acquire P | No | No | 1.42 | 175 | 248.50 | 1,825 |
13 Dec 23 | Sandeep Allam | Class A Common Stock | Buy | Acquire P | No | No | 1.4 | 647 | 905.80 | 3,436 |
13 Dec 23 | Feroz Syed | Class A Common Stock | Buy | Acquire P | No | No | 1.36 | 200 | 272.00 | 1,650 |
12 Dec 23 | Sandeep Allam | Class A Common Stock | Buy | Acquire P | No | No | 1.4 | 425 | 595.00 | 2,789 |
11 Dec 23 | Sandeep Allam | Class A Common Stock | Buy | Acquire P | No | No | 1.37 | 362 | 495.94 | 2,364 |
8 Dec 23 | Sandeep Allam | Class A Common Stock | Buy | Acquire P | No | No | 1.3 | 193 | 250.90 | 2,002 |
7 Dec 23 | Sandeep Allam | Class A Common Stock | Buy | Acquire P | No | No | 1.27 | 206 | 261.62 | 1,809 |
6 Dec 23 | Sandeep Allam | Class A Common Stock | Buy | Acquire P | No | No | 1.29 | 398 | 513.42 | 1,603 |
6 Dec 23 | Feroz Syed | Class A Common Stock | Buy | Acquire P | No | No | 1.33 | 200 | 266.00 | 1,450 |
News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
24 Apr 24
Syra Health Secures Statewide Healthcare Contract In Missouri
28 Mar 24
Syra Health Q4 EPS $(0.16) Misses $(0.09) Estimate, Sales $1.77M Miss $2.23M Estimate
25 Mar 24
Syra Health Expects FY24 Revenue Of $9M-$11M Vs $10.64M Est
25 Mar 24
Syra Health FY23 EPS $(0.60) Vs $(0.70) YoY; Revenue $5.5M Vs $5.6M YoY
25 Mar 24
Press releases
Syra Health Wins Award to Develop Health Equity Accelerator Plan for the City of Portland in Maine
24 Apr 24
Syra Health and Maricopa County Partner for Third Public Health Training
17 Apr 24
Syra Health's "Syrenity" Research Study Protocol Approved by Institutional Review Board
3 Apr 24
Syra Health Secures Statewide Healthcare Contract in Missouri
28 Mar 24
Syra Health Announces Fourth-Quarter and Full-Year 2023 Financial Results. Projects 2024 Revenue Growth of 64% to 100%.
25 Mar 24